Figure 2.

Marker immunostaining in tumor and uninvolved liver. Sections were immunostained as described and comparison samples are shown of HCC and surrounding non-tumor liver from the same specimens for CD133, EpCAM, CD90 and CD44.

Zeng et al. BMC Cancer 2012 12:584   doi:10.1186/1471-2407-12-584
Download authors' original image